HRP20110890T4 - Dihidroäśalkon sliäśan aspalatinu, ekstrakti iz nefermentiranog crvenog grma i postupci njegovog dobivanja - Google Patents

Dihidroäśalkon sliäśan aspalatinu, ekstrakti iz nefermentiranog crvenog grma i postupci njegovog dobivanja

Info

Publication number
HRP20110890T4
HRP20110890T4 HRP20110890AT HRP20110890T HRP20110890T4 HR P20110890 T4 HRP20110890 T4 HR P20110890T4 HR P20110890A T HRP20110890A T HR P20110890AT HR P20110890 T HRP20110890 T HR P20110890T HR P20110890 T4 HRP20110890 T4 HR P20110890T4
Authority
HR
Croatia
Prior art keywords
unfermed
aspalatine
dihydrocalcon
bulgaria
extremes
Prior art date
Application number
HRP20110890AT
Other languages
English (en)
Croatian (hr)
Inventor
Bruno Frank
Wilfried Dimpfel
Original Assignee
Kneipp Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38805677&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20110890(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Kneipp Gmbh filed Critical Kneipp Gmbh
Publication of HRP20110890T1 publication Critical patent/HRP20110890T1/hr
Publication of HRP20110890T4 publication Critical patent/HRP20110890T4/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Saccharide Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HRP20110890AT 2007-10-23 2008-09-05 Dihidroäśalkon sliäśan aspalatinu, ekstrakti iz nefermentiranog crvenog grma i postupci njegovog dobivanja HRP20110890T4 (xx)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07020728A EP2053050B1 (de) 2007-10-23 2007-10-23 Aspalathin-ähnliches Dihydrochalcon und Verfahren zur Herstellung
EP08801873.4A EP2069334B2 (de) 2007-10-23 2008-09-05 Aspalathin-ähnliches dihydrochalcon, extrakte aus unfermentiertem rotbusch und verfahren zur herstellung
PCT/EP2008/007279 WO2009052895A1 (de) 2007-10-23 2008-09-05 Aspalathin-ähnliches dihydrochalcon, extrakte aus unfermentiertem rotbusch und verfahren zur herstellung

Publications (2)

Publication Number Publication Date
HRP20110890T1 HRP20110890T1 (hr) 2011-12-31
HRP20110890T4 true HRP20110890T4 (xx) 2015-02-27

Family

ID=38805677

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20110890AT HRP20110890T4 (xx) 2007-10-23 2008-09-05 Dihidroäśalkon sliäśan aspalatinu, ekstrakti iz nefermentiranog crvenog grma i postupci njegovog dobivanja

Country Status (10)

Country Link
US (1) US20100222423A1 (https=)
EP (2) EP2053050B1 (https=)
JP (1) JP5527900B2 (https=)
AT (2) ATE522524T1 (https=)
DK (2) DK2053050T3 (https=)
ES (2) ES2372203T3 (https=)
HR (1) HRP20110890T4 (https=)
PL (2) PL2053050T3 (https=)
PT (2) PT2053050E (https=)
WO (1) WO2009052895A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8877717B2 (en) 2007-03-12 2014-11-04 Zadec Aps Anti-diabetic extract of rooibos
JP6797408B2 (ja) 2014-11-06 2020-12-09 国立大学法人 長崎大学 新規アルツハイマー病治療薬
JP6735224B2 (ja) * 2016-01-28 2020-08-05 花王株式会社 アストロサイトのグルコース代謝活性化剤
JP7244273B2 (ja) * 2018-12-27 2023-03-22 株式会社 伊藤園 ルイボス茶飲料の製造方法
CN109932448A (zh) * 2019-03-29 2019-06-25 完美（广东）日用品有限公司 一种线叶金雀花及其制品中有效成分的含量测定方法
CN115104730A (zh) * 2022-06-28 2022-09-27 北京姿美堂生物技术股份有限公司 一种改善睡眠的组合物、线叶金雀花-芦笋睡眠改善液、茶粉的制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2895298B2 (ja) * 1991-12-27 1999-05-24 株式会社ユニエ 活性酸素消去・除去剤
JPH05246866A (ja) * 1992-03-06 1993-09-24 Ruibosuteii Japan:Kk 脳代謝促進・脳機能改善剤
JPH11116429A (ja) † 1997-10-13 1999-04-27 Mikimoto Pharmaceut Co Ltd 化粧品原料および化粧品
JP2001316239A (ja) * 2000-05-10 2001-11-13 Mikimoto Pharmaceut Co Ltd 皮膚外用剤
KR100421233B1 (ko) * 2001-09-10 2004-03-11 한국원자력연구소 식품, 의약품 및 화장품 제조용 천연물의 색도 개선 방법 및 이의 방법에 의해 색도가 개선된 천연물 추출물
ZA200303674B (en) * 2002-02-20 2005-04-26 Benedict Technology Holdings P Antioxidant composition.
JP4637491B2 (ja) * 2004-03-01 2011-02-23 株式会社東洋発酵 抗アレルギー用組成物
DE102004052800B4 (de) * 2004-10-30 2017-02-23 Südzucker Aktiengesellschaft Mannheim/Ochsenfurt Verbesserte Trägerformulierungen
DE102005004438B4 (de) * 2005-01-31 2007-12-20 Raps Gmbh & Co. Kg Rooibos-Extrakt mit erhöhtem Aspalathingehalt, Verfahren zur Herstellung eines solchen Rooibos-Extraktes und kosmetisches Mittel enthaltend einen solchen Rooibos-Extrakt
JP2007161661A (ja) * 2005-12-15 2007-06-28 Pola Chem Ind Inc アドバンスド・グリケーション・エンドプロダクツを分解するための化粧料とその製造法
US8877717B2 (en) † 2007-03-12 2014-11-04 Zadec Aps Anti-diabetic extract of rooibos

Also Published As

Publication number Publication date
DK2069334T4 (da) 2014-12-08
PL2069334T3 (pl) 2012-04-30
EP2069334B1 (de) 2011-11-16
EP2069334B2 (de) 2014-11-05
ATE522524T1 (de) 2011-09-15
JP5527900B2 (ja) 2014-06-25
ES2373509T3 (es) 2012-02-06
PL2069334T5 (pl) 2015-06-30
HRP20110890T1 (hr) 2011-12-31
PT2069334E (pt) 2011-12-30
JP2011501755A (ja) 2011-01-13
ES2372203T3 (es) 2012-01-17
DK2069334T3 (da) 2012-01-23
ATE533763T1 (de) 2011-12-15
ES2373509T5 (es) 2015-02-16
PT2053050E (pt) 2011-12-09
EP2053050B1 (de) 2011-08-31
WO2009052895A1 (de) 2009-04-30
DK2053050T3 (da) 2011-11-21
US20100222423A1 (en) 2010-09-02
EP2069334A1 (de) 2009-06-17
EP2053050A1 (de) 2009-04-29
PL2053050T3 (pl) 2012-01-31

Similar Documents

Publication Publication Date Title
HRP20110890T4 (xx) Dihidroäśalkon sliäśan aspalatinu, ekstrakti iz nefermentiranog crvenog grma i postupci njegovog dobivanja
EP2422819A3 (en) Compositions and their uses directed to Huntingtin
EP2178870A4 (en) INDOL AND INDAZONE COMPOUNDS AS AN INHIBITORS OF CELL NECROSIS
AR053334A1 (es) Pirazolilcarboxanilidas
AR068369A1 (es) Sal de xinafoato de n4-[(2,2-difluor-4h-benzo[1,4]oxazin-3-on)-6-il]-5-fluor-n2-[3-(metilaminocarbonilmetilenoxi)-fenil]2,4-pirimidindiamina"
EG25488A (en) Fungicidal mixtures of thiophene derivative
GT201200164A (es) "nuevos compuestos de espiropiperidina"
JO2973B1 (en) Fumarate salt for (alpha-beta-R) -6-bromo-alpha-[2- (methylamino) ethyl-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinoline ethanol
MX2007013623A (es) Preparacion externa para la piel.
CO6280474A2 (es) Composicion farmaceutica para el tratamiento de la eyaculacion precoz
ZA201101579B (en) Salts of n-[6-cis-2,6-dimethylmorpholin-4yl)pyridine-3yl]-2-methyl-4'-(trifluoromethoxy)[1,1'-biphenyl]-3-carboxamide
PE20020351A1 (es) Composiciones farmaceuticas que comprenden acido 5-metil-2-(2'-cloro-6'-fluoroanilino)fenilacetico como inhibidor de la ciclooxigenasa-2
UA106352C2 (ru) Гербицидная композиция, способ ее получения, гербицидно активное средство, содержащее композицию, применение композиции, способ борьбы с нежелательным ростом растений (варианты)
FR2902999B1 (fr) Utilisation de derives c-glycoside a titre d'actif prodesquamant
WO2008022745A8 (de) Formulierungen zur kontrollierten freisetzung agrochemischer wirkstoffe
GEP20125646B (en) 3-(2,2,2-trimethylhydrazinium) propionate salts for ischemic heart disease treatment
WO2011075799A3 (en) Oral antidepressant formulation
TNSN08461A1 (en) Crystalline forms of 4-[2-(4-methylphenylsulfanyl)-phenyl]piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of neuropathic pain.
JP2006089487A5 (https=)
WO2012028922A3 (en) Controlled release pharmaceutical compositions of milnacipran
UA95801C2 (ru) Кристаллические формы 4-[2-(4-метилфенилсульфанил)-фенил]пиперидина с комбинированным ингибированием обратного захвата серотонина и норэпинефрина для лечения невропатической боли
PL2160190T3 (pl) Pochodne 5beta, 14beta-androstanu przydatne w leczeniu chorób będących wynikiem zwłóknienia organu
BRPI1008780A2 (pt) "composto ou éster ou sal farmacologicamente aceitável do mesmo, e, medicamento."
WO2010062144A3 (ko) 에타크리닉 산을 포함하는 트란스글루타미나제 관련 질환 예방 또는 치료용 조성물 및 그를 이용하는 트란스글루타미나제 관련 질환 예방 또는 치료 방법
EP2067473A3 (en) Medical use of 3-(2,2,2-trimethylhydrazinium) propionate salts